Impact BioMedical Inc. (IBO)

NYSEAMERICAN: IBO · Real-Time Price · USD
0.5910
+0.0113 (1.95%)
Sep 2, 2025, 12:59 PM - Market open
1.95%
Market Cap7.20M
Revenue (ttm)7,000
Net Income (ttm)-38.47M
Shares Out 12.19M
EPS (ttm)-3.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume47,029
Open0.5650
Previous Close0.5797
Day's Range0.5650 - 0.5975
52-Week Range0.3621 - 6.1700
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2025

About IBO

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can i... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Sep 16, 2024
Employees 2
Stock Exchange NYSEAMERICAN
Ticker Symbol IBO
Full Company Profile

Financial Performance

Financial Statements

News

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue

HOUSTON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBO) is pleased to announce that the US Patent and Trademark Office has issued U.S. patent No. 12,357,584 B2 entitled “Composition an...

15 days ago - GlobeNewsWire

Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“Impact BioMedical”) (NYSE American: IBO), a...

2 months ago - GlobeNewsWire

Impact Biomedical Inc. Announcement Stock Activity/Pricing

HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare so...

5 months ago - GlobeNewsWire

Impact BioMedical Inc. to Present at The Microcap Conference

HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare sol...

7 months ago - GlobeNewsWire

Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease

HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian Intellect...

11 months ago - GlobeNewsWire

Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates

HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare sol...

11 months ago - GlobeNewsWire

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

HOUSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (“IBO”) is pleased to announce that the US Patent and Trademark Office has issued U.S. Patent No. 11,985,973 entitled “Insect Repelli...

1 year ago - GlobeNewsWire

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) --  Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the clos...

1 year ago - GlobeNewsWire

Impact BioMedical Inc. Announces Pricing of Initial Public Offering

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricin...

1 year ago - GlobeNewsWire

Impact BioMedical IPO Registration Document (S-1)

Impact BioMedical has filed to go public with an IPO on the NYSE American.

1 year ago - SEC